BICO has entered into an agreement to acquire QInstruments, a market leader in advanced sample preparation automation for biomedical and life science research and clinical diagnostics.
BICO Group AB (publ) ("BICO") has entered into an agreement with the shareholders of QInstruments GmbH ("QInstruments") to acquire all outstanding shares, on a cash- and debt-free basis, and under the assumption that the working capital at closing equals the normalized working capital, to a purchase price of 61.25 million euro (the "Acquisition"), of which 3 million euro will be paid upon achievement of predetermined revenue and EBITDA milestones. Approximately 13 percent of the purchase price will be paid in newly issued shares of series B in BICO (the “Consideration Shares”), and the
